CG Oncology (CGON) Shares Outstanding (2023 - 2026)

CG Oncology has reported Shares Outstanding for 4 years, with the latest figure at $88.0 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 15.46% year-over-year to $88.0 million; the trailing twelve-month figure through Mar 2026 stood at $88.0 million (up 15.46% YoY), and the FY2025 full-year result was $80.7 million, up 5.95% from the prior year.
• Shares Outstanding for Q1 2026 stood at $88.0 million, up from $80.7 million in the prior quarter.
• The five-year high for Shares Outstanding was $88.0 million in Q1 2026, with the low at $3.9 million in Q1 2023.
• Historically, Shares Outstanding has averaged $53.4 million across 4 years, with a median of $67.5 million in 2024.
• Annual changes were most pronounced in 2024 — Shares Outstanding surged 1627.96% — and 2025, when it increased 5.95%.
• CG Oncology's Shares Outstanding stood at $5.2 million in 2023, then jumped by 1358.27% to $76.2 million in 2024, then grew by 5.95% to $80.7 million in 2025, then rose by 9.07% to $88.0 million in 2026.
• The last three Shares Outstanding figures came in at $88.0 million (Q1 2026), $80.7 million (Q4 2025), and $78.3 million (Q3 2025), per Business Quant data.